Augmedix, Inc.
AUGX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $257,086 | $58,373 | $91,082 | $131,231 |
| - Cash | $46,342 | $21,988 | $41,587 | $20,762 |
| + Debt | $25,846 | $19,756 | $14,837 | $14,951 |
| Enterprise Value | $236,590 | $56,141 | $64,332 | $125,420 |
| Revenue | $44,855 | $30,933 | $22,165 | $16,483 |
| % Growth | 45% | 39.6% | 34.5% | – |
| Gross Profit | $21,526 | $13,954 | $10,007 | $6,794 |
| % Margin | 48% | 45.1% | 45.1% | 41.2% |
| EBITDA | -$15,675 | -$21,807 | -$14,474 | -$13,284 |
| % Margin | -34.9% | -70.5% | -65.3% | -80.6% |
| Net Income | -$19,171 | -$26,527 | -$17,160 | -$14,737 |
| % Margin | -42.7% | -85.8% | -77.4% | -89.4% |
| EPS Diluted | -0.44 | -0.71 | -0.59 | -0.55 |
| % Growth | 38% | -20.3% | -7.3% | – |
| Operating Cash Flow | -$15,441 | -$16,773 | -$18,592 | -$14,399 |
| Capital Expenditures | -$3,105 | -$1,408 | -$611 | -$647 |
| Free Cash Flow | -$18,546 | -$18,181 | -$19,203 | -$15,046 |